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June Supplement 2011108S AbstractsConclusions: Lesion characteristics and patient
factors can predict long-term patency after intervention.
This comprehensive evaluation of over 1800 lesions
provides a basis for development of a LSS to standardize
lesion classification and allow for comparisons between
centers based on lesion location, combinations of
lesions, patient co-morbidities, and treatment modali-
ties.
Table 1. Factors Predicting Loss of Patency
Cox
coefficient HR (95% CI) P-value Score
Poor runoff 0.21 1.23 (1.06-1.44) 0.0079 1
Lesion Calcification 0.22 1.25 (1.07-1.45) 0.0043 1
CHF 0.28 1.32 (1.12-1.56) 0.0009 2
Diabetes 0.28 1.33 (1.13-1.56) 0.0005 2
High Grade Stenosis 0.31 1.36 (1.12-1.66) 0.0022 2
Lesion Length 100-
199mm 0.37 1.44 (1.19-1.76) 0.0002 2
Current Smoker 0.39 1.48 (1.19-1.84) 0.0004 3
Lesion Length 200 mm 0.43 1.54 (1.28-1.57) 0.0001 3
Chronic Total Occlusion 0.44 1.55 (1.26-1.91) 0.001 3
Factors evaluated but not achieving significance included age, sex, BMI,
CRI, CAD, indication, stenosis79%, and length99mm.
Table 2. Patency Based on LSS
Lesion Severity
Score
Patency at 12
months
(95% CI)
Patency at 24
months
(95% CI)
Patency at 36
months
(95%CI)
Patency at 48
months
(95%CI)
0-1 83% (73%-89%) 75% (64%-83%) 73% (62%-82%) 67% (53%-78%)
2-3 76% (69%-81%) 63% (56%-70%) 58% (49%-65%) 55% (45%-63%)
4-7 62% (58%-66%) 50% (46%-54%) 45% (41%-50%) 37% (31%-43%)
7 50% (45%-55%) 32% (27%-37%) 23% (18%-29%) 16% (10%-23%
Author Disclosures: N. Egorova: Nothing to disclose;
A. Graham: Nothing to disclose; S. Z. Khan: Nothing
to disclose; I. Kim: Nothing to disclose; J. F. McKin-
sey: Nothing to disclose; A. J. Meltzer: Nothing to
disclose.
RR23.
Natural Course of Spontaneous Isolated Superior Mes-
enteric Artery Dissection: Follow-up Observation after
Conservative Treatment
Yang Jin Park1, Kwang-Bo Park2, Young-Nam Roh1,
Young Soo Do2, Dong-Ik Kim1, Duk-Kyung Kim3,
Young-Wook Kim1. 1Vascular Surgery, Samsung Medical
Center, Sungkyunkwan University School of Medicine,
Seoul, Republic of Korea; 2Radiology, Samsung Medical
Center, Sungkyunkwan University School of Medicine,
Seoul, Republic of Korea; 3Cardiology, Samsung Medical
Center, Sungkyunkwan University School of Medicine,
Seoul, Republic of Korea fObjectives: To determine the natural course of spontane-
us isolated superior mesenteric artery dissection (SISMAD).
Methods: Among 58 patients with SISMAD, 53 pa-
ients were treated by conservative management and 5
reated with intervention (stent 1, surgery 4). 39 patients
reated by conservative management were followed up
eriodically using CT angiography in outpatient clinic. We
lassified SISMAD into three major categories according to
he angiographic finding. We also investigated the angio-
raphic change (progression of dissection, change of type,
cclusion or remodeling, luminal patency) and clinical
ourse (resolution and recurrence of pain).
Results: We found five (12.8%) cases of complete
ealing (remodeling) of SISMAD during the follow-up
eriods (mean 7.7 months, range 3.1-16 months). We also
bserved the decrease of dissection length in 10 (25.6%)
nd the extent of thrombosis in false lumen in 17 (43.6%).
o change was found in 16 (41%). No patients had pro-
ression of their lesion on the follow-up CT angiography.
he angiographic change of SISMAD was not associated
ith the symptom severity nor the use of anticoagulation
herapy. During the clinical follow-up, 36 (92.3%) patients
howed complete pain relief without recurrence of abdom-
nal pain with conservative management.
Conclusions: After conservative management, we ob-
erved the morphologic change of SISMAD and benign
linical course. Based on this observation, patients with
ISMAD could be treated conservatively.
uthor Disclosures: Y. Do: Nothing to disclose; D. Kim:
othing to disclose; D. Kim: Nothing to disclose; Y. Kim:
othing to disclose; K. Park: Nothing to disclose; Y.
ark: Nothing to disclose; Y. Roh: Nothing to disclose.
R24.
ssessment of Anaerobic Threshold in Cardiopulmo-
ary Exercise Testing as an Independent Predictor of
utcome in Patients Undergoing Abdominal Aortic
neurysm (AAA) repair
unaid A. Khan, Fayyaz A. Mazari, Nehmiah Samuel,
eorge Smith, Risha Gohil, Ian Chetter, Peter McCollum.
cademic Vascular Surgery, University of Hull, Hull,
nited Kingdom
Objectives: The aim of this study was to assess the role
f anaerobic threshold (AT) in cardiopulmonary exercise
esting (CPET) as an independent predictor of outcome in
atients undergoing Abdominal aortic aneurysm (AAA)
epair.
Methods:Analysis of a prospectively collected database
f patients recruited in a randomised controlled trial for
re-operative risk assessments of elective AAA repair pa-
ients. Peri-operative parameters & outcomes were re-
orded for all patients. Primary end point was 30 day
ortality. Intergroup analysis (alive vs. dead) was per-ormed using SPSS 16.0.
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Volume 53, Number 17S Abstracts 109SResults: 30 patients [26 men, median age 75 years
(IQR: 68-78)] were included in the study. Median Anaer-
obic threshold was 12.67 ml/min/kg (IQR: 8.6-16.42).
Median hospital stay was 7 days (IQR: 5-12), post opera-
tive complications were observed in 10% (n3) and mor-
tality rate was 7% (n2).
Inter-group Analysis: There was a significant difference
(P0.042) between the two groups in the AT [median AT,
Alive: 12.76 ml/min/kg (range; 5.52-22.37), Dead: 6.67
ml/min/kg (range; 6.08-7.26)]. However, there was no
statistically significant difference between the two groups
for basic demographics, co-morbidities and pre-operative
medications.
Conclusions:Anaerobic threshold in cardiopulmonary
exercise testing may be used as an independent predictor of
outcome in patients undergoing AAA repair. Further stud-
ies are required to establish its role as an independent
predictor of morbidity & mortality in elective AAA
patients.
Author Disclosures: I. Chetter: Nothing to disclose; R.
Gohil: Nothing to disclose; J. A. Khan: Nothing to dis-
close; F. A. Mazari: Nothing to disclose; P. McCollum:
Nothing to disclose; N. Samuel: Nothing to disclose; G.
Smith: Nothing to disclose.
RR25.
Mechano-Chemical Endovenous Ablation in Great and
Small Saphenous Vein Incompetence Using ClariVein
TM: Initial Results of an Innovative Tumescentless
Technique
Doeke Boersma1, Ramon van Eekeren2, Debora Werson1,
Michel Reijnen2, Rob van de Mortel1, Jean Paul de Vries1.
1St. Antonius Hospital Nieuwegein, Nieuwegein, Nether-
lands; 2Alysis Zorggroep Rijnstate, Arnhem, Netherlands
Objectives: Most endovenous techniques for treatment
of great saphenous vein incompetence use thermal energy,
which requires instillation of tumescence anaesthesia andmay
lead to heat-related nerve damage. The innovative mechano-
chemical endovenous ablation (MECEA) of the great and
small saphenous veinwas recently developed to induces occlu-
sion by endovenous mechanical damage combined with infu-
sion of a liquid sclerosans. Initial results.
Methods: Prospective study of 110 consecutive pa-
tients, treated for 126 insufficient veins withMECEA using
ClariVeinTM device (Vascular Insights, USA) and aetox-
ysklerol. Initial technical success (obliteration at post-pro-
cedural duplex scan), complications, patient satisfaction
and visual analogue scale painscore (VAS) were assessed.
Follow up included duplex scan of treated veins.
Inclusion criteria: 1. Venous incompetence of GSV,
SSV or anterolateral side branches (ASB). 2. Vein diameter
of 3 to 11mm. 3. Length of incompetence  15 cm.
Results: From June to December 2010 126 legs were
treated (107 GSV, 13 SSV, 6 ASB). The median length of
treated veins was 37cm (16-52). Initial technical success of fECEA was 100%. Median (VAS) painscore was 3 (0-10).
o nerve damage occurred. The majority of patients al-
eady had 6 weeks follow-up duplex scan: 76 of 77 patients
98%) had obliteration of the treated vein. In one patient
otal recanalisation occurred, she had successful renewed
ECEA. Four patients had 6 months duplex scans and all
eins remained obliterated. No patients suffered from ma-
or complications; local hematoma at the puncture site was
een in 26%and superficial trombophlebitis in 23%, resolv-
ng within a week.
Conclusions: Mechanochemical obliteration of long
egment GSV, SSV and ASB incompetence is feasible with
00% initial technical success in this first large series. VAS
cores are low and no tumescent anesthesia is necessary.
hort-term follow-up is encouraging, and a Dutch registry
as been started to gather longer-term follow-up.
uthor Disclosures: D. Boersma: Nothing to disclose; J.
e Vries: Nothing to disclose; M. Reijnen: Nothing to
isclose; R. van de Mortel: Nothing to disclose; R. van
ekeren: Nothing to disclose; D. Werson: Nothing to
isclose.
R26.
he Impact of Ablation of Incompetent Veins on Ulcer
ealing
eter F. Lawrence1, Micheal Harlander-Locke2, Ali Alk-
aifi1, Steven Farley1, David Rigberg1, Juan Carlos Jime-
ez1, Brian G. DeRubertis1, Hugh Gelabert1. 1Vascular
urgery, UCLA, Los Angeles, CA; 2University of San Di-
go, San Diego, CA
Objectives: We assessed the impact of endovenous
blation of incompetent veins on the healing rate of venous
lcers in patients who had failed conventional compression
herapy.
Methods: Venous disease was CEAP classified. Pa-
ients with CEAP 6 ulcers were treated with weekly com-
ression in a dedicated wound care center. Ulcer size and
epth were tracked prospectively. Those ulcers that showed
o measurable improvement after 5 weeks of compres-
ion therapy underwent ablation of at least one incompe-
ent vein.
Results: We performed 140 consecutive endovenous
blation procedures (74 axial and 66 perforating) on 110
enous ulcers in 88 limbs. Ulcers had been present for
16mo with an initial ulcer area of 236 cm2. Following
uccessful ablation, the healing rate for healed ulcers im-
roved from 3.49.4%/mo to 75.526.3%/mo
p0.001)(Fig 1). Healing rate by vein ablation location
as: GSV6.4cm2/mo, SSV4.8cm2/mo, posterior tib-
al perforator veins2.9cm2/mo. After a minimum obser-
ation period of 4.5 months (mean follow-up 111.25
o), 84% of patients healed in 14214 days. Twelve
atients with 26 ulcers did not heal (Fig 2): 2 patients died
rom unrelated illnesses, 6 patients are still actively healing,
